Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD44 in cancer.
Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. Naor D, et al. Among authors: golan i. Crit Rev Clin Lab Sci. 2002 Nov;39(6):527-79. doi: 10.1080/10408360290795574. Crit Rev Clin Lab Sci. 2002. PMID: 12484499 Review.
CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice.
Naor D, Nedvetzki S, Walmsley M, Yayon A, Turley EA, Golan I, Caspi D, Sebban LE, Zick Y, Garin T, Karussis D, Assayag-Asherie N, Raz I, Weiss L, Slavin S, Golan I. Naor D, et al. Among authors: golan i. Ann N Y Acad Sci. 2007 Sep;1110:233-47. doi: 10.1196/annals.1423.025. Ann N Y Acad Sci. 2007. PMID: 17911438 Review.
The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation.
Eshkar Sebban L, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S, Amital H, Rubinow A, Golan I, Naor D, Zick Y, Golan I. Eshkar Sebban L, et al. Among authors: golan i. J Immunol. 2007 Jul 15;179(2):1225-35. doi: 10.4049/jimmunol.179.2.1225. J Immunol. 2007. PMID: 17617615 Free article.
Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody.
Golan I, Nedvetzki S, Golan I, Eshkar-Sebban L, Levartovsky D, Elkayam O, Caspi D, Aamar S, Amital H, Rubinow A, Naor D. Golan I, et al. J Autoimmun. 2007 Mar-May;28(2-3):99-113. doi: 10.1016/j.jaut.2007.02.007. Epub 2007 Mar 23. J Autoimmun. 2007. PMID: 17383158
A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor.
Nedvetzki S, Golan I, Assayag N, Gonen E, Caspi D, Gladnikoff M, Yayon A, Naor D. Nedvetzki S, et al. Among authors: golan i. J Clin Invest. 2003 Apr;111(8):1211-20. doi: 10.1172/JCI17100. J Clin Invest. 2003. PMID: 12697740 Free PMC article.
Expression of Ly-6, a marker for highly malignant murine tumor cells, is regulated by growth conditions and stress.
Treister A, Sagi-Assif O, Meer M, Smorodinsky NI, Anavi R, Golan I, Meshel T, Kahana O, Eshel R, Katz BZ, Shevach E, Witz IP. Treister A, et al. Among authors: golan i. Int J Cancer. 1998 Jul 17;77(2):306-13. doi: 10.1002/(sici)1097-0215(19980717)77:2<306::aid-ijc22>;2-7. Int J Cancer. 1998. PMID: 9650569
Simvastatin induces apoptosis of fibroblast-like synoviocytes.
Litinsky I, Golan I, Yaron M, Yaron I, Caspi D, Elkayam O. Litinsky I, et al. Among authors: golan i. Open Rheumatol J. 2009 Sep 7;3:35-40. doi: 10.2174/1874312900903010035. Open Rheumatol J. 2009. PMID: 19771181 Free PMC article.
Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers.
Sherman L, Alloul N, Golan I, Durst M, Baram A. Sherman L, et al. Among authors: golan i. Int J Cancer. 1992 Feb 1;50(3):356-64. doi: 10.1002/ijc.2910500305. Int J Cancer. 1992. PMID: 1310488
Somatostatin treatment attenuates proteinuria and prevents weight loss in NZB/W F1 mice.
Paran D, Bernheim J, Golan I, Caspi D, Bernheim J, Benchetrit S. Paran D, et al. Among authors: golan i. Lupus. 2006;15(8):526-31. doi: 10.1191/0961203306lu2346oa. Lupus. 2006. PMID: 16942006
PARP1 Deficiency Reduces Tumour Growth by Decreasing E2F1 Hyperactivation: A Novel Mechanism in the Treatment of Cancer.
Iglesias P, Seoane M, Golán I, Castro-Piedras I, Fraga M, Arce VM, Costoya JA. Iglesias P, et al. Among authors: golan i. Cancers (Basel). 2020 Oct 10;12(10):2907. doi: 10.3390/cancers12102907. Cancers (Basel). 2020. PMID: 33050515 Free PMC article.
38 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page